ECCPM General Information

The Challenges of Continuous Pharmaceutical Manufacturing

  • Improve quality
  • Improve process robustness
  • Speed to market
  • Platform development
  • Flexible and efficient supply chains
  • Make more complex products
  • Personalise/precision medicine

The Drivers for Modernising Pharmaceutical Manufacturing

  • Process and material understanding
  • QA/QC strategy
  • Real-time release testing
  • Predictive modelling
  • Regulatory alignment
  • Economic alignment
  • Human resource/expertise development

Our Approach for Continuous Manufacturing Development

  • An interdisciplinary team of process, pharmaceutical and chemical engineers and researchers
  • A diverse partner matrix consisting of pharma, technology/equipment providers and academic/scientific collaborators
  • A platform for pre-competitive information exchange and networking
  • Flexible intellectual property right (IPR) arrangments to enable an agile and focused exploration of specific interests

The Consortium

Benefits and Expected Outcome

  • Application of existing CM platform technologies for the promotion of continuous manufacturing of partner-specific drug products
  • Examination of the impact of continuous manufacturing routes on costs (production, materials, footprint, etc.), efficiency and yield
  • Implementation of concepts for integrated quality control strategies
  • Utilisation of continuous manufacturing knowledge and experience
  • Access to consolidated scientific expertise (e.g. simulation, material science, PAT)
  • Access to equipment and instrumentation suppliers without exposure to CAPEX
  • Access to an international and focused network
  • Co-authorship of scientific publications and relevant speeches